Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.83e-09	114	121	10	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	4.18e-09	124	121	10	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.10e-08	137	121	10	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	2.68e-07	192	121	10	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	DPP4 USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 ADAMTS12 USP17L17 DPEP2 USP17L15 USP17L13	1.70e-04	654	121	13	GO:0008233
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC17 MUC4	2.17e-04	4	121	2	GO:0030197
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	2.83e-09	125	119	10	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.12e-08	144	119	10	GO:0070646
GeneOntologyBiologicalProcess	regulation of chromatin organization	ING3 PHF8 BAZ1A KMT2A MLLT3	3.29e-06	40	119	5	GO:1902275
GeneOntologyBiologicalProcess	definitive hemopoiesis	SP1 SP3 KMT2A RBFOX2	1.67e-05	27	119	4	GO:0060216
GeneOntologyBiologicalProcess	embryonic placenta development	SP1 SP3 MDFI BPTF HEY2 HECTD1	6.63e-05	119	119	6	GO:0001892
GeneOntologyBiologicalProcess	anterior/posterior pattern specification	ROR2 ZEB2 BPTF BMPR2 GLI2 HEY2 KMT2A MLLT3	9.44e-05	247	119	8	GO:0009952
GeneOntologyBiologicalProcess	embryonic organ development	SP1 SP3 ROR2 SIX4 MDFI BPTF C2CD3 GLI2 ARID2 HEY2 KMT2A HECTD1	9.83e-05	561	119	12	GO:0048568
GeneOntologyBiologicalProcess	anatomical structure homeostasis	TEX15 ZEB2 CD34 KMT2A DMD MUC4 MUC5AC MUC6 WNK3	1.40e-04	334	119	9	GO:0060249
GeneOntologyBiologicalProcess	tissue homeostasis	TEX15 ZEB2 CD34 KMT2A DMD MUC4 MUC5AC MUC6 WNK3	1.40e-04	334	119	9	GO:0001894
GeneOntologyBiologicalProcess	placenta development	SP1 SP3 MDFI BPTF BMPR2 HEY2 HECTD1	1.48e-04	197	119	7	GO:0001890
GeneOntologyBiologicalProcess	astrocyte development	ROR1 ROR2 ZEB2 OPRPN	1.55e-04	47	119	4	GO:0014002
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP17L21 RANBP2 RNF186 UBE4B USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 NEDD4 USP17L18 USP17L17 HECTD1 UBE2Z USP17L15 USP17L13	2.25e-04	1009	119	16	GO:0070647
GeneOntologyBiologicalProcess	chordate embryonic development	SP1 SP3 ROR2 SIX4 MDFI ZEB2 BPTF BMPR2 C2CD3 GLI2 HEY2 TAB1 HECTD1 USP17L15 USP17L13	2.27e-04	906	119	15	GO:0043009
GeneOntologyCellularComponent	Golgi lumen	MUC3B MUC16 F8 MUC17 MUC4 MUC5AC MUC6 MUC7	2.33e-07	109	121	8	GO:0005796
Domain	HABP4_PAI-RBP1	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L18 USP17L17 USP17L13	3.24e-14	16	122	8	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L18 USP17L17 USP17L13	3.24e-14	16	122	8	IPR006861
Domain	USP_CS	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L13	4.35e-10	66	122	9	IPR018200
Domain	USP_1	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L13	7.47e-10	70	122	9	PS00972
Domain	UCH	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L13	8.51e-10	71	122	9	PF00443
Domain	USP_2	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L13	8.51e-10	71	122	9	PS00973
Domain	USP_3	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L13	9.67e-10	72	122	9	PS50235
Domain	USP_dom	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L13	9.67e-10	72	122	9	IPR028889
Domain	Peptidase_C19_UCH	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L13	9.67e-10	72	122	9	IPR001394
Domain	Sp1_fam	SP1 SP3 SP4	3.16e-05	10	122	3	IPR030450
Domain	Factor_5/8	F5 F8	4.23e-05	2	122	2	IPR024715
Domain	Tyr_kinase_rcpt_ROR	ROR1 ROR2	4.23e-05	2	122	2	IPR016247
Domain	SEA	MUC3B MUC16 MUC17	9.39e-05	14	122	3	SM00200
Domain	CD34_antigen	PODXL CD34	1.26e-04	3	122	2	PF06365
Domain	CD34/Podocalyxin	PODXL CD34	1.26e-04	3	122	2	IPR013836
Domain	PHD	ING3 PHF8 BPTF BAZ1A KMT2A	1.31e-04	75	122	5	PF00628
Domain	VWF_type-D	MUC4 MUC5AC MUC6	1.43e-04	16	122	3	IPR001846
Domain	VWFD	MUC4 MUC5AC MUC6	1.43e-04	16	122	3	PS51233
Domain	VWD	MUC4 MUC5AC MUC6	1.43e-04	16	122	3	SM00216
Domain	VWD	MUC4 MUC5AC MUC6	1.43e-04	16	122	3	PF00094
Domain	Znf_PHD-finger	ING3 PHF8 BPTF BAZ1A KMT2A	1.68e-04	79	122	5	IPR019787
Domain	DDT	BPTF BAZ1A	2.52e-04	4	122	2	PF02791
Domain	PHD	ING3 PHF8 BPTF BAZ1A KMT2A	2.93e-04	89	122	5	SM00249
Domain	Znf_PHD	ING3 PHF8 BPTF BAZ1A KMT2A	3.25e-04	91	122	5	IPR001965
Domain	SEA	MUC3B MUC16 MUC17	3.82e-04	22	122	3	PF01390
Domain	ZF_PHD_2	ING3 PHF8 BPTF BAZ1A KMT2A	3.97e-04	95	122	5	PS50016
Domain	ZF_PHD_1	ING3 PHF8 BPTF BAZ1A KMT2A	4.17e-04	96	122	5	PS01359
Domain	DDT	BPTF BAZ1A	4.18e-04	5	122	2	SM00571
Domain	Cu-oxidase_3	F5 F8	4.18e-04	5	122	2	IPR011707
Domain	DDT_dom	BPTF BAZ1A	4.18e-04	5	122	2	IPR018501
Domain	MULTICOPPER_OXIDASE1	F5 F8	4.18e-04	5	122	2	PS00079
Domain	WHIM1_dom	BPTF BAZ1A	4.18e-04	5	122	2	IPR028942
Domain	WHIM2_dom	BPTF BAZ1A	4.18e-04	5	122	2	IPR028941
Domain	Cu_oxidase_CS	F5 F8	4.18e-04	5	122	2	IPR033138
Domain	WSD	BPTF BAZ1A	4.18e-04	5	122	2	PF15613
Domain	WHIM1	BPTF BAZ1A	4.18e-04	5	122	2	PF15612
Domain	Cu-oxidase_3	F5 F8	4.18e-04	5	122	2	PF07732
Domain	SEA	MUC3B MUC16 MUC17	4.38e-04	23	122	3	PS50024
Domain	SEA_dom	MUC3B MUC16 MUC17	4.38e-04	23	122	3	IPR000082
Domain	DDT	BPTF BAZ1A	6.24e-04	6	122	2	PS50827
Domain	Cu_oxidase_Cu_BS	F5 F8	6.24e-04	6	122	2	IPR002355
Domain	Zinc_finger_PHD-type_CS	ING3 PHF8 BPTF BAZ1A	8.63e-04	65	122	4	IPR019786
Domain	BROMODOMAIN_2	BPTF BAZ1A KMT2A	2.42e-03	41	122	3	PS50014
Domain	Bromodomain	BPTF BAZ1A KMT2A	2.59e-03	42	122	3	IPR001487
Domain	BROMO	BPTF BAZ1A KMT2A	2.59e-03	42	122	3	SM00297
Domain	-	BPTF BAZ1A KMT2A	2.59e-03	42	122	3	1.20.920.10
Domain	C8	MUC5AC MUC6	2.68e-03	12	122	2	PF08742
Domain	TIL	MUC5AC MUC6	2.68e-03	12	122	2	PF01826
Domain	Znf_FYVE_PHD	ING3 PHF8 BPTF BAZ1A KMT2A	2.80e-03	147	122	5	IPR011011
Domain	Unchr_dom_Cys-rich	MUC5AC MUC6	3.15e-03	13	122	2	IPR014853
Domain	C8	MUC5AC MUC6	3.15e-03	13	122	2	SM00832
Domain	WW	FNBP4 NEDD4 DMD	3.58e-03	47	122	3	PF00397
Domain	TIL_dom	MUC5AC MUC6	3.66e-03	14	122	2	IPR002919
Domain	-	F5 F8	3.66e-03	14	122	2	2.60.40.420
Domain	PROTEIN_KINASE_TYR	ROR1 ROR2 OBSCN RYK	3.76e-03	97	122	4	PS00109
Domain	Tyr_kinase_AS	ROR1 ROR2 OBSCN RYK	3.76e-03	97	122	4	IPR008266
Domain	WW	FNBP4 NEDD4 DMD	3.80e-03	48	122	3	SM00456
Domain	-	MUC16 MUC17	4.20e-03	15	122	2	3.30.70.960
Domain	IGc2	ROR1 ROR2 OBSCN MCAM LINGO2 LRRC4C	4.48e-03	235	122	6	SM00408
Domain	Ig_sub2	ROR1 ROR2 OBSCN MCAM LINGO2 LRRC4C	4.48e-03	235	122	6	IPR003598
Domain	WW_DOMAIN_1	FNBP4 NEDD4 DMD	4.51e-03	51	122	3	PS01159
Domain	WW_DOMAIN_2	FNBP4 NEDD4 DMD	4.51e-03	51	122	3	PS50020
Domain	WW_dom	FNBP4 NEDD4 DMD	4.76e-03	52	122	3	IPR001202
Domain	Kringle_CS	ROR1 ROR2	5.40e-03	17	122	2	IPR018056
Domain	KRINGLE_1	ROR1 ROR2	5.40e-03	17	122	2	PS00021
Domain	KR	ROR1 ROR2	5.40e-03	17	122	2	SM00130
Domain	Kringle	ROR1 ROR2	5.40e-03	17	122	2	IPR000001
Domain	KRINGLE_2	ROR1 ROR2	5.40e-03	17	122	2	PS50070
Domain	Kringle	ROR1 ROR2	5.40e-03	17	122	2	PF00051
Pathway	REACTOME_RAS_PROCESSING	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	8.59e-12	45	90	9	MM15671
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC17 MUC4 MUC5AC MUC6 MUC7	4.35e-10	16	90	6	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC17 MUC4 MUC5AC MUC6 MUC7	6.69e-10	17	90	6	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC17 MUC4 MUC5AC MUC6 MUC7	5.29e-09	23	90	6	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC17 MUC4 MUC5AC MUC6 MUC7	1.19e-08	26	90	6	M27483
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 TAB1 USP17L15 USP17L13	1.54e-07	221	90	11	M27578
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC17 MUC4 MUC5AC MUC6	1.78e-07	21	90	5	MM15706
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 ADAMTS12 MUC17 MUC4 MUC5AC MUC6 MUC7	2.41e-07	68	90	7	M27303
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 SP3 RANBP2 USP17L20 USP17L11 SEC24A USP17L24 MUC16 USP17L5 PEX14 USP17L10 F5 F8 PHC1 USP17L18 ADAMTS12 USP17L17 MUC17 TAB1 MUC4 MUC5AC MUC6 MUC7 UBE2Z HSPA8 USP17L15 USP17L13	2.66e-07	1475	90	27	M19806
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 TAB1 USP17L15 USP17L13	3.68e-07	191	90	10	MM15289
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 SP3 RANBP2 USP17L20 USP17L11 SEC24A MUC16 USP17L5 PEX14 USP17L10 F5 F8 PHC1 USP17L18 ADAMTS12 USP17L17 MUC17 TAB1 MUC4 MUC5AC MUC6 UBE2Z HSPA8 USP17L15 USP17L13	1.17e-06	1389	90	25	MM15307
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC17 MUC4 MUC5AC MUC6 MUC7	2.64e-06	62	90	6	M546
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC16 TAB2 MUC17 TAB1 MUC4 MUC5AC MUC6 MUC7	3.02e-06	140	90	8	M27484
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 TAB1 USP17L15 USP17L13	3.05e-06	299	90	11	M27574
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 TAB1 USP17L15 USP17L13	6.42e-06	262	90	10	MM15286
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC16 ADAMTS12 MUC17 MUC4 MUC5AC MUC6 MUC7	6.77e-06	111	90	7	M27416
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC16 ADAMTS12 MUC17 MUC4 MUC5AC MUC6 MUC7	3.53e-05	143	90	7	M27275
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC17 MUC4 MUC5AC MUC6	3.93e-05	60	90	5	MM15636
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC16 ADAMTS12 MUC17 MUC4 MUC5AC MUC6	6.84e-05	109	90	6	MM15164
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.92e-04	318	90	9	MM15278
Pathway	PID_CMYB_PATHWAY	SP1 TAB2 CD34 TAB1 HSPA8	1.97e-04	84	90	5	M195
Pathway	WP_ECTODERM_DIFFERENTIATION	PODXL ROR2 PHF8 TSC22D1 BAZ1A DMD	2.92e-04	142	90	6	M39575
Pathway	WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE	SP1 SP3	3.98e-04	5	90	2	M45554
Pathway	BIOCARTA_INTRINSIC_PATHWAY	F5 F8 SERPING1	4.06e-04	23	90	3	M15997
Pathway	BIOCARTA_INTRINSIC_PATHWAY	F5 F8 SERPING1	4.06e-04	23	90	3	MM1427
Pathway	KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION	BMP2K KMT2A MLLT3	5.88e-04	26	90	3	M47439
Pathway	BIOCARTA_TERC_PATHWAY	SP1 SP3	5.95e-04	6	90	2	MM1564
Pathway	BIOCARTA_TERC_PATHWAY	SP1 SP3	5.95e-04	6	90	2	M22047
Pathway	BIOCARTA_TERT_PATHWAY	SP1 SP3	8.29e-04	7	90	2	MM1541
Pathway	REACTOME_DISEASES_OF_METABOLISM	MUC16 ADAMTS12 MUC17 MUC4 MUC5AC MUC6 MUC7	1.08e-03	250	90	7	M27554
Pathway	PID_WNT_NONCANONICAL_PATHWAY	ROR2 TAB2 TAB1	1.09e-03	32	90	3	M23
Pathway	BIOCARTA_TERT_PATHWAY	SP1 SP3	1.10e-03	8	90	2	M22015
Pathway	REACTOME_CARGO_CONCENTRATION_IN_THE_ER	SEC24A F5 F8	1.20e-03	33	90	3	M27591
Pathway	REACTOME_CARGO_CONCENTRATION_IN_THE_ER	SEC24A F5 F8	1.54e-03	36	90	3	MM15300
Pathway	REACTOME_REGULATION_OF_CDH11_GENE_TRANSCRIPTION	SP1 ZEB2	1.75e-03	10	90	2	M48016
Pathway	REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX	TAB2 TAB1	1.75e-03	10	90	2	MM15647
Pathway	REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX	TAB2 TAB1	1.75e-03	10	90	2	M27925
Pathway	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	F5 F8 SERPING1	1.95e-03	39	90	3	M2844
Pathway	REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	F5 F8 SERPING1	1.95e-03	39	90	3	MM14559
Pathway	REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY	TAB2 TAB1	2.14e-03	11	90	2	M29827
Pathway	REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX	TAB2 TAB1	2.14e-03	11	90	2	M27885
Pathway	KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_NFKB_SIGNALING_PATHWAY	TAB2 TAB1	2.14e-03	11	90	2	M47493
Pathway	REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY	TAB2 TAB1	2.14e-03	11	90	2	MM15668
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.82e-17	33	123	10	20228807
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.82e-17	21	123	9	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.82e-17	21	123	9	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.82e-17	21	123	9	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.82e-17	21	123	9	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.82e-17	21	123	9	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.82e-17	21	123	9	18980247
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	2.57e-17	34	123	10	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	2.57e-17	34	123	10	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	2.57e-17	34	123	10	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	2.57e-17	34	123	10	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	2.57e-17	34	123	10	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	2.57e-17	34	123	10	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	2.57e-17	34	123	10	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	2.57e-17	34	123	10	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	2.57e-17	34	123	10	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	2.57e-17	34	123	10	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	2.57e-17	34	123	10	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	2.57e-17	34	123	10	21448158
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	3.07e-17	22	123	9	9154835
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	3.59e-17	35	123	10	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	3.59e-17	35	123	10	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	4.95e-17	36	123	10	20147298
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	6.77e-17	37	123	10	20228808
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	8.03e-17	24	123	9	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.25e-16	25	123	9	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.91e-16	26	123	9	35816173
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	6.06e-16	29	123	9	32527007
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.43e-13	50	123	9	31806660
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MCAM MUC16 MUC17 MUC4 MUC5AC MUC6 MUC7	1.79e-13	18	123	7	18834073
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	DOCK3 SP1 SP3 SP4 UBAP2 ING3 PEX14 WTAP NEDD4 USF3 GLI2 IPCEF1 ARID2 CBFA2T2 ZFR	3.93e-11	430	123	15	35044719
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SLAIN2 HIVEP2 UBAP2 SEC24A ROR2 TAB2 NEDD4 FSIP2 BMPR2 C2CD3 DST MTUS1 KMT2A ANKRD17 MPHOSPH9 TAB1 HECTD1 WNK3	1.57e-09	861	123	18	36931259
Pubmed	A human MAP kinase interactome.	SP1 RANBP2 HIVEP2 NEB TSC22D1 USF3 DST KANSL1 ARID2 ANKRD17 MPHOSPH9 DMD RBFOX2	2.01e-08	486	123	13	20936779
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SP1 SP3 SP4 ING3 ZC3H13 SIX4 PHF8 PHC1 HIVEP3 BPTF ZBTB44 TSC22D1 BAZ1A ARID2 ZFR TAF6	2.92e-08	808	123	16	20412781
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SP1 RANBP2 ING3 ZC3H13 FNBP4 SIX4 PHF8 EMSY WTAP BPTF ZBTB44 DST KANSL1 BAZ1A KMT2A ZFR TAF6 LRIF1 HSPA8 RBFOX2	2.95e-08	1294	123	20	30804502
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	RANBP2 UBAP2 CDKN2AIP NACA PEX14 EMSY STAU1 DST BAZ1A ARID2 NUFIP2 KMT2A ANKRD17 ZFR TAF6 GOLGA5 HSPA8	3.53e-08	934	123	17	33916271
Pubmed	Complex phenotype of mice homozygous for a null mutation in the Sp4 transcription factor gene.	SP1 SP3 SP4	4.32e-08	3	123	3	11532028
Pubmed	Dystrophin Dp71 expression is down-regulated during myogenesis: role of Sp1 and Sp3 on the Dp71 promoter activity.	SP1 SP3 DMD	4.32e-08	3	123	3	15550398
Pubmed	Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3.	SP1 SP3 SP4	4.32e-08	3	123	3	7559627
Pubmed	Analysis of Sp transcription factors in the postmortem brain of chronic schizophrenia: a pilot study of relationship to negative symptoms.	SP1 SP3 SP4	4.32e-08	3	123	3	23540600
Pubmed	Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.	SP1 SP3 SP4	4.32e-08	3	123	3	26967243
Pubmed	Curcumin decreases specificity protein expression in bladder cancer cells.	SP1 SP3 SP4	4.32e-08	3	123	3	18593936
Pubmed	Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.	SP1 SP3 SP4	4.32e-08	3	123	3	21919647
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	ZNF280A SLAIN2 RANBP2 CACUL1 CDKN2AIP MCAM EMSY STAU1 NUFIP2 TAB1 TAF6 HSPA8	6.48e-08	444	123	12	34795231
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SP1 RANBP2 UBE4B ZC3H13 FNBP4 PHF8 EMSY WTAP BPTF KANSL1 CBFA2T2 KMT2A ANKRD17 TAF6 HSPA8	1.08e-07	774	123	15	15302935
Pubmed	The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.	SLAIN2 BMP2K PODXL CDKN2AIP TUBGCP3 NUFIP2 ANKRD17 TAB1 DMD HSPA8	1.17e-07	298	123	10	30737378
Pubmed	Human transcription factor protein interaction networks.	SP1 UBAP2 ING3 SEC24A NACA SIX4 PHF8 ZEB2 EMSY STAU1 BPTF DST KANSL1 GLI2 ARID2 KMT2A ANKRD17 ZFR TAF6 LRIF1	1.47e-07	1429	123	20	35140242
Pubmed	Sp4 is expressed in retinal neurons, activates transcription of photoreceptor-specific genes, and synergizes with Crx.	SP1 SP3 SP4	1.72e-07	4	123	3	15781457
Pubmed	Upregulation of MUC6 mucin gene expression by NFkappaB and Sp factors.	SP1 SP3 MUC6	1.72e-07	4	123	3	15979574
Pubmed	Sp2 is the only glutamine-rich specificity protein with minor impact on development and differentiation in myelinating glia.	SP1 SP3 SP4	1.72e-07	4	123	3	27889927
Pubmed	Transcription factors YY1, Sp1 and Sp3 modulate dystrophin Dp71 gene expression in hepatic cells.	SP1 SP3 DMD	1.72e-07	4	123	3	27143785
Pubmed	Induction of dystrophin Dp71 expression during neuronal differentiation: opposite roles of Sp1 and AP2alpha in Dp71 promoter activity.	SP1 SP3 DMD	1.72e-07	4	123	3	19943855
Pubmed	Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.	SP1 SP3 SP4	4.29e-07	5	123	3	20538607
Pubmed	Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.	SP1 SP3 SP4	4.29e-07	5	123	3	10547281
Pubmed	Reciprocal regulation of expression of the human adenosine 5'-triphosphate binding cassette, sub-family A, transporter 2 (ABCA2) promoter by the early growth response-1 (EGR-1) and Sp-family transcription factors.	SP1 SP3 SP4	4.29e-07	5	123	3	12560508
Pubmed	MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.	MUC4 MUC5AC MUC6	4.29e-07	5	123	3	16475027
Pubmed	Interaction network of human early embryonic transcription factors.	RANBP2 HIVEP2 SIX4 ZEB2 EMSY BPTF BAZ1A ARID2 KMT2A LRIF1	5.27e-07	351	123	10	38297188
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SLAIN2 UBAP2 FNBP4 PHF8 EMSY BPTF ARID2 NUFIP2 KMT2A ZFR TAB1 TAF6	6.24e-07	549	123	12	38280479
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	SLAIN2 UBAP2 CDKN2AIP ZC3H13 NACA TAB2 STAU1 NUFIP2 ZFR TAB1 HSPA8 RBFOX2	6.49e-07	551	123	12	34728620
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	DOCK3 USP17L21 USP17L20 USP17L11 USP17L5 UNC93A USP17L10 USP17L18 TSC22D1 USP17L17 USP17L15 WNK3 USP17L13	8.46e-07	674	123	13	37196079
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC16 MUC5AC MUC6	8.57e-07	6	123	3	19110483
Pubmed	Nkx3.1 binds and negatively regulates the transcriptional activity of Sp-family members in prostate-derived cells.	SP1 SP3 SP4	8.57e-07	6	123	3	16201967
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	HIVEP2 UBE4B EPB41L4B ROR2 AFF3 OBSCN FNBP4 PEX14 TEP1 HIVEP3 BPTF TSC22D1 BMPR2 USF3 GLI2 CBFA2T2 ANKRD17 HECTD1 RBFOX2	1.25e-06	1489	123	19	28611215
Pubmed	POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1.	SP1 SP3 SP4	1.50e-06	7	123	3	12004059
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	RANBP2 UBAP2 CDKN2AIP ZC3H13 FNBP4 EMSY STAU1 BPTF BAZ1A ARID2 NUFIP2 KMT2A ZFR TAF6 HSPA8	1.50e-06	954	123	15	36373674
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	RANBP2 UBAP2 ZC3H13 FNBP4 WTAP BAZ1A ARID2 CBFA2T2 TUBGCP3 NUFIP2 KMT2A ANKRD17 ZFR HSPA8	1.93e-06	847	123	14	35850772
Pubmed	Non-canonical Wnt Signaling through Ryk Regulates the Generation of Somatostatin- and Parvalbumin-Expressing Cortical Interneurons.	ROR1 ROR2 ZEB2 RYK	2.45e-06	27	123	4	31257105
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	DPP4 TOPAZ1 ROR1 ROR2 MUC16 RYK BPTF ZFR TAB1 HSPA8	2.64e-06	420	123	10	28065597
Pubmed	A census of human transcription factors: function, expression and evolution.	SP1 SP3 SP4 HIVEP2 SIX4 ZEB2 RXRG HIVEP3 TSC22D1 USF3 GLI2 HEY2 KMT2A MLLT3	4.29e-06	908	123	14	19274049
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	RANBP2 EPB41L4B SEC24A ROR1 ROR2 TAB2 NUFIP2 GOLGA5	4.68e-06	263	123	8	34702444
Pubmed	Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.	PHF8 EMSY BPTF TAF6 LRIF1 HSPA8	5.50e-06	124	123	6	20850016
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	SLAIN2 SP4 RANBP2 CDKN2AIP ZEB2 EMSY STAU1 BPTF ARID2 TUBGCP3 KMT2A ZFR TAF6 LRIF1 HSPA8	8.63e-06	1103	123	15	34189442
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	SLAIN2 RANBP2 BMP2K SEC24A TAB2 PHF8 EMSY C2CD3 MTUS1 MPHOSPH9 TAB1 GOLGA5 RBFOX2	1.09e-05	853	123	13	28718761
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	SLAIN2 RANBP2 OBSCN TAB2 NEB ZBTB44 DST TUBGCP3 HEY2 HSPA8	1.15e-05	497	123	10	23414517
Pubmed	A phospho/methyl switch at histone H3 regulates TFIID association with mitotic chromosomes.	PHF8 BPTF TAF6	1.20e-05	13	123	3	20953165
Pubmed	Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial.	F5 F8	1.24e-05	2	123	2	26599105
Pubmed	Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium. Implications for the mechanisms of aortic aneurysm and heart failure.	SP1 SP3	1.24e-05	2	123	2	10825178
Pubmed	HPV8 activates cellular gene expression mainly through Sp1/3 binding sites.	SP1 SP3	1.24e-05	2	123	2	31299490
Pubmed	The molecular basis of factor V and VIII procofactor activation.	F5 F8	1.24e-05	2	123	2	19765210
Pubmed	ROR1 and ROR2 expression in pancreatic cancer.	ROR1 ROR2	1.24e-05	2	123	2	34763666
Pubmed	Acute myeloid leukemia with t(9;11)(p21-22;q23): common properties of dysregulated ras pathway signaling and genomic progression characterize de novo and therapy-related cases.	KMT2A MLLT3	1.24e-05	2	123	2	20395514
Pubmed	MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer.	MUC4 MUC5AC	1.24e-05	2	123	2	18475301
Pubmed	Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias.	KMT2A MLLT3	1.24e-05	2	123	2	32768438
Pubmed	Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.	MUC16 MUC5AC	1.24e-05	2	123	2	22220206
Pubmed	Identification of CD34+ and CD34- leukemia-initiating cells in MLL-rearranged human acute lymphoblastic leukemia.	CD34 KMT2A	1.24e-05	2	123	2	25538041
Pubmed	Sp1/Sp3 transcription factors regulate hallmarks of megakaryocyte maturation and platelet formation and function.	SP1 SP3	1.24e-05	2	123	2	25538045
Pubmed	CD34 promotes satellite cell motility and entry into proliferation to facilitate efficient skeletal muscle regeneration.	CD34 DMD	1.24e-05	2	123	2	21997891
Pubmed	Clinicopathological features of superficial non-ampurally duodenal epithelial tumor; gastric phenotype of histology correlates to higher malignant potency.	MUC5AC MUC6	1.24e-05	2	123	2	28321513
Pubmed	Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors.	SP1 SP3	1.24e-05	2	123	2	31164147
Pubmed	Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular trafficking.	F5 F8	1.24e-05	2	123	2	28057741
Pubmed	Impact of MLL::AF9 Gene Rearrangement on Survival of Acute Myeloid Leukaemia Patients: An Insight into Pakistani Population.	KMT2A MLLT3	1.24e-05	2	123	2	38576284
Pubmed	Uncoupling of growth plate maturation and bone formation in mice lacking both Schnurri-2 and Schnurri-3.	HIVEP2 HIVEP3	1.24e-05	2	123	2	20404140
Pubmed	Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus.	SP1 SP3	1.24e-05	2	123	2	17681019
Pubmed	Endothelial Sp1/Sp3 are essential to the effect of captopril on blood pressure in male mice.	SP1 SP3	1.24e-05	2	123	2	37735515
Pubmed	Immune response as a possible mechanism of long-lasting disease control in spontaneous remission of MLL/AF9-positive acute myeloid leukemia.	KMT2A MLLT3	1.24e-05	2	123	2	21959947
Pubmed	The factor VIII D1241E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels.	F5 F8	1.24e-05	2	123	2	15735794
Pubmed	Sp1 and Sp3 Are the Transcription Activators of Human ek1 Promoter in TSA-Treated Human Colon Carcinoma Cells.	SP1 SP3	1.24e-05	2	123	2	26807725
Pubmed	Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide.	SP1 SP3	1.24e-05	2	123	2	15951564
Pubmed	Transcription factors Sp1 and Sp3 regulate basal transcription of the human IRF-3 gene.	SP1 SP3	1.24e-05	2	123	2	22464952
Pubmed	Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism.	F5 F8	1.24e-05	2	123	2	17287628
Interaction	ELF1 interactions	SP1 EMSY BPTF KANSL1 ARID2 KMT2A DMD TAF6 LRIF1	5.12e-08	126	117	9	int:ELF1
Interaction	FHL2 interactions	SP1 SP3 SP4 ING3 BMP2K EMSY BMPR2 MTUS1 NUFIP2 ANKRD17 ZFR LRIF1 WNK3	5.23e-07	396	117	13	int:FHL2
Interaction	HDAC2 interactions	SLAIN2 SP1 SP3 BMP2K PODXL CDKN2AIP ZEB2 EMSY PHC1 BPTF BAZ1A TUBGCP3 NUFIP2 KMT2A ANKRD17 TAB1 DMD TAF6 HSPA8	5.62e-07	865	117	19	int:HDAC2
Interaction	YY1 interactions	SP1 SP3 ARHGAP26 MDFI EMSY NEDD4 BPTF KANSL1 ARID2 NUFIP2 KMT2A TAF6 LRIF1	2.39e-06	454	117	13	int:YY1
Interaction	NUP93 interactions	DPP4 SP1 RANBP2 ZC3H13 ROR1 RYK STAU1 TSC22D1 HECTD1 HSPA8	3.87e-06	269	117	10	int:NUP93
Interaction	YWHAQ interactions	HIVEP2 UBAP2 SEC24A ZC3H13 ROR2 TAB2 NEB WTAP STAU1 NEDD4 DST MTUS1 BAZ1A TUBGCP3 KMT2A ANKRD17 MPHOSPH9 TAB1 HECTD1 HSPA8	6.39e-06	1118	117	20	int:YWHAQ
Interaction	NFYC interactions	SP1 SP4 EMSY USF3 DST ARID2 KMT2A TAF6	9.13e-06	177	117	8	int:NFYC
Interaction	HDAC1 interactions	SP1 SP3 RANBP2 PEX14 TAB2 ZEB2 EMSY STAU1 BPTF DST BAZ1A GLI2 HEY2 KMT2A ANKRD17 TAF6 GOLGA5 HECTD1 HSPA8	2.03e-05	1108	117	19	int:HDAC1
Interaction	KLF8 interactions	SP1 ING3 PHF8 ZEB2 EMSY STAU1 NEDD4 BPTF ARID2 TAF6	2.23e-05	329	117	10	int:KLF8
Interaction	NANOG interactions	SP1 RANBP2 MUC16 EMSY WTAP PHC1 BPTF TUBGCP3 NUFIP2 ZFR HSPA8 RBFOX2	2.36e-05	481	117	12	int:NANOG
Interaction	LHX5 interactions	ARHGAP26 GLI2 DMD	3.04e-05	11	117	3	int:LHX5
Interaction	HNF4A interactions	SP1 ING3 ZEB2 EMSY BPTF KANSL1 ARID2 DMD TAF6	3.29e-05	275	117	9	int:HNF4A
Interaction	BTRC interactions	SP1 HIVEP2 UBAP2 UBE4B NACA PHF8 WTAP NEDD4 GLI2 TUBGCP3 NUFIP2 HEY2 ZFR HSPA8 RBFOX2	4.27e-05	775	117	15	int:BTRC
Interaction	NAA40 interactions	RANBP2 UBAP2 CDKN2AIP NACA PEX14 EMSY STAU1 DST BAZ1A ARID2 NUFIP2 KMT2A ANKRD17 ZFR TAF6 GOLGA5 HSPA8	4.92e-05	978	117	17	int:NAA40
Interaction	NFIX interactions	ING3 SIX4 ZEB2 EMSY BPTF ARID2 KMT2A TAF6	5.45e-05	227	117	8	int:NFIX
Interaction	ELF4 interactions	EMSY BPTF KANSL1 ARID2 TAF6 LRIF1	5.66e-05	115	117	6	int:ELF4
Interaction	UBAP2 interactions	UBAP2 TEP1 STAU1 NUFIP2 ANKRD17 ZFR RBFOX2	6.11e-05	170	117	7	int:UBAP2
Interaction	FMR1 interactions	DPP4 RANBP2 UBAP2 EMSY WTAP STAU1 NEDD4 NUFIP2 ANKRD17 ZFR HECTD1 HSPA8	6.74e-05	536	117	12	int:FMR1
Interaction	NUP43 interactions	RANBP2 CDKN2AIP ZC3H13 PHF8 EMSY FSIP2 BPTF DST KANSL1 BAZ1A ARID2 KMT2A TAF6	6.99e-05	625	117	13	int:NUP43
Interaction	SIN3A interactions	SP1 SP3 TAB2 BPTF CBFA2T2 HEY2 KMT2A TAF6 HECTD1 HSPA8	7.52e-05	380	117	10	int:SIN3A
Interaction	S100A10 interactions	UBAP2 MCAM NEB ZFR TAB1 HSPA8	7.87e-05	122	117	6	int:S100A10
Interaction	DYNLT1 interactions	EMSY BMPR2 DST MTUS1 NUFIP2 KMT2A HECTD1 LRIF1	8.28e-05	241	117	8	int:DYNLT1
Interaction	MEN1 interactions	UBAP2 UBE4B ZC3H13 FNBP4 PHF8 EMSY WTAP BPTF KANSL1 BAZ1A ARID2 CBFA2T2 NUFIP2 KMT2A ANKRD17 ZFR HSPA8	9.18e-05	1029	117	17	int:MEN1
Interaction	SMAD7 interactions	TAB2 NEDD4 ZBTB44 TSC22D1 BMPR2 TAB1	9.83e-05	127	117	6	int:SMAD7
Interaction	YWHAG interactions	SLAIN2 HIVEP2 UBAP2 SEC24A ZC3H13 ROR2 TAB2 NEDD4 C2CD3 DST MTUS1 BAZ1A NUFIP2 KMT2A ANKRD17 MPHOSPH9 TAB1 HECTD1 HSPA8	1.01e-04	1248	117	19	int:YWHAG
Interaction	FKBP3 interactions	NACA STAU1 NEDD4 FSIP2 HECTD1 HSPA8	1.17e-04	131	117	6	int:FKBP3
Interaction	CRX interactions	SP1 SP3 SP4 ROR2 MDFI ZEB2 ARID2 LRIF1	1.19e-04	254	117	8	int:CRX
Interaction	RBBP4 interactions	SP1 SP3 RASSF10 ZEB2 EMSY BPTF BAZ1A TUBGCP3 KMT2A TAF6 HECTD1 HSPA8	1.26e-04	573	117	12	int:RBBP4
Interaction	MYB interactions	PHF8 ZEB2 EMSY KANSL1 KMT2A HSPA8	1.27e-04	133	117	6	int:MYB
Interaction	PHLPP1 interactions	RANBP2 UBAP2 NACA MCAM NEB NEDD4 NUFIP2 ANKRD17 HSPA8	1.42e-04	333	117	9	int:PHLPP1
Interaction	POU5F1 interactions	SP1 NACA MUC16 EMSY PHC1 STAU1 NEDD4 BPTF GLI2 TUBGCP3 ANKRD17 HSPA8	1.51e-04	584	117	12	int:POU5F1
Interaction	NUP50 interactions	RANBP2 UBAP2 CACUL1 NACA FNBP4 TSC22D1 ARID2 KMT2A ZFR	1.70e-04	341	117	9	int:NUP50
Interaction	WNK1 interactions	RANBP2 TSC22D1 TAF6 HSPA8 WNK3 RBFOX2	1.74e-04	141	117	6	int:WNK1
Interaction	EXOC1 interactions	STAU1 DST KANSL1 GOLGA5 HECTD1 HSPA8	1.88e-04	143	117	6	int:EXOC1
Interaction	RNF43 interactions	RANBP2 EPB41L4B SEC24A ROR1 ROR2 OBSCN TAB2 NUFIP2 GOLGA5 HSPA8	1.95e-04	427	117	10	int:RNF43
Interaction	USP7 interactions	DOCK3 SP1 SP3 SP4 UBAP2 LINGO2 TEX15 PHF8 NEB WTAP STAU1 ZBTB44 TSC22D1 DST GLI2 IPCEF1 ZFR DMD WNK3	1.95e-04	1313	117	19	int:USP7
Interaction	CBLL2 interactions	ZC3H13 MDFI WTAP	2.02e-04	20	117	3	int:CBLL2
Interaction	H2BC21 interactions	OBSCN FNBP4 PHF8 NEB PHC1 BPTF C2CD3 USF3 BAZ1A ARID2 KMT2A CRYBG1 LRIF1	2.03e-04	696	117	13	int:H2BC21
Interaction	YWHAH interactions	SLAIN2 HIVEP2 UBAP2 SEC24A ZC3H13 ROR2 TAB2 NEDD4 C2CD3 DST MTUS1 KMT2A ANKRD17 MPHOSPH9 TAB1 HECTD1 WNK3	2.09e-04	1102	117	17	int:YWHAH
Interaction	SMC5 interactions	RANBP2 UBAP2 CDKN2AIP ZC3H13 FNBP4 EMSY STAU1 BPTF BAZ1A ARID2 NUFIP2 KMT2A ZFR TAF6 HECTD1 HSPA8	2.17e-04	1000	117	16	int:SMC5
Interaction	H3C1 interactions	GARIN5B DPP4 NACA PHF8 NEB STAU1 BPTF BAZ1A ARID2 KMT2A MLLT3 ZFR TAF6 LRIF1 HSPA8	2.27e-04	901	117	15	int:H3C1
Interaction	KLF6 interactions	SP1 ING3 EMSY STAU1 ARID2	2.31e-04	95	117	5	int:KLF6
Interaction	SUPT16H interactions	DPP4 RANBP2 ZC3H13 ROR1 TEX15 NEB STAU1 ETAA1 HECTD1 HSPA8	2.57e-04	442	117	10	int:SUPT16H
Interaction	BAG2 interactions	DPP4 SP1 UBAP2 FNBP4 TAB2 TEP1 PHC1 BPTF TUBGCP3 TAB1 HSPA8 WNK3	2.69e-04	622	117	12	int:BAG2
Interaction	H3-4 interactions	DOCK3 PHF8 EMSY BPTF USF3 KMT2A DMD TAF6 LRIF1 HSPA8	2.86e-04	448	117	10	int:H3-4
Interaction	ELF2 interactions	PHF8 EMSY BPTF KANSL1 KMT2A TAF6	3.01e-04	156	117	6	int:ELF2
Interaction	SMAD6 interactions	NEDD4 TSC22D1 BMPR2 TAB1	3.14e-04	56	117	4	int:SMAD6
Interaction	PRMT1 interactions	SLAIN2 UBAP2 UBE4B CDKN2AIP ZC3H13 NACA TAB2 STAU1 NUFIP2 ZFR TAB1 TAF6 LRIF1 HSPA8 RBFOX2	3.14e-04	929	117	15	int:PRMT1
Cytoband	4p16.1	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.49e-14	79	122	10	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	4.90e-10	222	122	10	chr4p16
Cytoband	4q13.3	OPRPN ANKRD17 MUC7	1.95e-04	42	122	3	4q13.3
GeneFamily	CD molecules\|Mucins	MUC3B MUC16 MUC17 MUC4 MUC5AC MUC6 MUC7	1.07e-12	21	70	7	648
GeneFamily	Zinc fingers C2H2-type\|Sp transcription factors	SP1 SP3 SP4	4.59e-06	9	70	3	755
GeneFamily	PHD finger proteins	ING3 PHF8 BPTF BAZ1A KMT2A	2.56e-05	90	70	5	88
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	ROR1 ROR2 OBSCN LINGO2 LRRC4C	3.99e-04	161	70	5	593
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	ROR1 ROR2 RYK	4.96e-04	40	70	3	321
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF3 MLLT3	5.23e-04	9	70	2	1280
GeneFamily	Zinc fingers RANBP2-type \|RNA binding motif containing	RANBP2 TAB2	2.96e-03	21	70	2	89
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	SP1 SP3 SP4 HIVEP2 ZEB2 HIVEP3 ZBTB44 GLI2	6.41e-03	718	70	8	28
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SP3 RANBP2 HIVEP2 BMP2K PODXL SEC24A ROR1 PEX14 TAB2 PHF8 ZEB2 RYK NEDD4 BPTF C2CD3 DST BAZ1A TUBGCP3 ANKRD17 MPHOSPH9 DMD RBFOX2	4.77e-11	856	120	22	M4500
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L21 EPB41L4B USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	1.06e-10	112	120	10	MM1095
Coexpression	MADAN_DPPA4_TARGETS	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	2.23e-10	86	120	9	MM1312
Coexpression	GERY_CEBP_TARGETS	USP17L21 USP17L20 USP17L11 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	5.51e-08	160	120	9	MM1155
Coexpression	NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN	ING3 ARHGAP26 PHC1 C2CD3 CBFA2T2 ANKRD17 MPHOSPH9 TAB1 DMD TAF6	4.73e-07	269	120	10	M41203
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	HIVEP2 SEC24A TAB2 RYK NEDD4 BPTF C2CD3 DST BAZ1A TUBGCP3 ANKRD17 RBFOX2	1.61e-06	466	120	12	M13522
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	ROR1 PEX14 ZEB2 DST MPHOSPH9 DMD	2.47e-06	84	120	6	M13008
Coexpression	GSE14308_TH17_VS_INDUCED_TREG_UP	SP3 ING3 MCAM NEB USF3 ETAA1 CRYBG1 LRIF1	4.04e-06	200	120	8	M3385
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	SP3 HIVEP2 BPTF DST MEGF9 MTUS1 BAZ1A CBFA2T2 TUBGCP3	1.03e-05	300	120	9	M8702
Coexpression	NABA_ECM_AFFILIATED	MUC16 OPRPN MUC17 MUC4 MUC5AC MUC6 MUC7	1.37e-05	170	120	7	M5880
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	SLAIN2 SP3 RANBP2 HIVEP2 FNBP4 TAB2 ZEB2 HIVEP3 BPTF ZBTB44 KANSL1 BAZ1A IPCEF1 ARID2 NUFIP2 KMT2A CRYBG1 ZFR TMEM123 HSPA8	1.40e-05	1492	120	20	M40023
Coexpression	PILON_KLF1_TARGETS_UP	BMP2K PODXL EMSY RYK C2CD3 TREML4 SERPING1 KMT2A MLLT3 ZFR HECTD1	2.06e-05	503	120	11	M2226
Coexpression	GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN	F5 BPTF USF3 MTUS1 IPCEF1 KMT2A MLLT3	2.72e-05	189	120	7	M3112
Coexpression	GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP	ING3 NACA TSC22D1 BMPR2 DPEP2 CBFA2T2 KMT2A	3.77e-05	199	120	7	M7596
Coexpression	GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP	DPP4 SP1 BMP2K ZC3H13 FNBP4 CBFA2T2 GOLGA5	3.90e-05	200	120	7	M3419
Coexpression	GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN	SP4 BMP2K ARHGAP26 FNBP4 BPTF BMPR2 ZFR	3.90e-05	200	120	7	M4979
Coexpression	PILON_KLF1_TARGETS_UP	BMP2K PODXL EMSY RYK C2CD3 TREML4 SERPING1 KMT2A MLLT3 ZFR HECTD1	4.00e-05	541	120	11	MM1061
Coexpression	GABRIELY_MIR21_TARGETS	ZBTB44 BMPR2 MEGF9 ADGRG2 CRYBG1 DMD HECTD1 WNK3	5.73e-05	289	120	8	M2196
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	RANBP2 AFF3 TIGD1 FNBP4 USF3 ARID2 NUFIP2 ZFR MPHOSPH9 HECTD1	6.71e-05	474	120	10	M40991
Coexpression	FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP	DPP4 HIVEP2 PODXL AFF3 TAB2 RYK MLLT3 ZFR DMD HSPA8 WNK3	8.30e-05	587	120	11	M40869
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	SP1 UBAP2 UBE4B BPTF BMPR2 KANSL1	1.84e-04	180	120	6	M8239
Coexpression	HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	UBAP2 NACA CRYBG1 MPHOSPH9 TMEM123	1.90e-04	115	120	5	M19849
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	SP3 CACUL1 PODXL ZC3H13 ARHGAP26 NACA TAB2 MDFI ZEB2 RXRG ETAA1 ANKRD17 MPHOSPH9 TMEM123	2.17e-04	1009	120	14	M157
Coexpression	ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN	DPP4 SP4 HIVEP2 UBE4B CDKN2AIP AFF3 TIGD1 BPTF ZBTB44 DPEP2 ARID2 KMT2A MPHOSPH9 HECTD1	2.23e-04	1012	120	14	M40864
Coexpression	AIZARANI_LIVER_C31_KUPFFER_CELLS_5	ZC3H13 PHF8 ZEB2 MEGF9 BAZ1A	2.32e-04	120	120	5	M39130
Coexpression	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN	MCAM TEX15 MTUS1 HEY2	2.56e-04	67	120	4	M9325
Coexpression	LIU_VMYB_TARGETS_UP	EPB41L4B SEC24A ARHGAP26 PHF8 MPHOSPH9	2.80e-04	125	120	5	M1584
Coexpression	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP	TSC22D1 BMPR2 USF3 MTUS1 DPEP2 IPCEF1	2.84e-04	195	120	6	M4201
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE	ARHGAP26 MCAM RXRG MTUS1 MLLT3 DMD	2.84e-04	195	120	6	M45684
Coexpression	FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	SP3 BMP2K NACA ZEB2 RYK TSC22D1 DST MEGF9 TMEM123 HSPA8	2.91e-04	568	120	10	M4023
Coexpression	GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN	TAB2 ZEB2 WTAP USF3 SERPING1 UBE2Z	3.00e-04	197	120	6	M7947
Coexpression	GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN	NEB PHC1 DST MTUS1 ADGRG2 ETAA1	3.00e-04	197	120	6	M9910
Coexpression	MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN	MCAM TEX15 MTUS1 HEY2	3.03e-04	70	120	4	MM809
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	ZC3H13 AFF3 MDFI NEDD4 KANSL1 NUFIP2 MLLT3 HSPA8 RBFOX2	3.06e-04	467	120	9	M1347
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP	SP3 UBAP2 UBE4B SEC24A EMSY DPEP2 CBFA2T2 ANKRD17 MPHOSPH9 GOLGA5	3.11e-04	573	120	10	M41006
Coexpression	GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN	RANBP2 GRIN2C STAU1 SERPING1 KMT2A MUC6	3.17e-04	199	120	6	M5242
Coexpression	GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP	ING3 ARHGAP26 FNBP4 F5 IPCEF1 KMT2A	3.17e-04	199	120	6	M4460
Coexpression	GSE22886_NAIVE_VS_MEMORY_TCELL_DN	HIVEP2 TAB2 WTAP GLI2 ZFR TMEM123	3.17e-04	199	120	6	M4417
Coexpression	GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP	NEB ZEB2 NEDD4 MEGF9 CRYBG1 TAF6	3.17e-04	199	120	6	M5769
Coexpression	GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP	CACUL1 CDKN2AIP AFF3 TAB2 IPCEF1 CBFA2T2	3.25e-04	200	120	6	M9447
Coexpression	GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN	DPP4 BMP2K AFF3 PHF8 WTAP TMEM123	3.25e-04	200	120	6	M5966
Coexpression	GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP	BMP2K EPB41L4B PODXL NEDD4 TSC22D1 CD34	3.25e-04	200	120	6	M4574
Coexpression	GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN	SLAIN2 ARHGAP26 WTAP KANSL1 MTUS1 CD34	3.25e-04	200	120	6	M6636
Coexpression	GSE21063_WT_VS_NFATC1_KO_BCELL_DN	SP1 SP4 HIVEP2 UBE4B ETAA1 MLLT3	3.25e-04	200	120	6	M8261
Coexpression	GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN	ROR2 FNBP4 TAB2 STAU1 TSC22D1 ZC3H12C	3.25e-04	200	120	6	M3714
Coexpression	GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN	CACUL1 PHF8 TEP1 KANSL1 MEGF9 KMT2A	3.25e-04	200	120	6	M8651
Coexpression	GSE6681_DELETED_FOXP3_VS_WT_TREG_DN	DOCK3 DPP4 UBE4B ZC3H13 ZEB2 MTUS1	3.25e-04	200	120	6	M6779
Coexpression	LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN	SLAIN2 CACUL1 UBE4B PEX14 EMSY HIVEP3 ZBTB44 C2CD3 KMT2A ZC3H12C TMEM123 HSPA8	3.37e-04	807	120	12	M14594
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	SLAIN2 SP1 HIVEP2 EPB41L4B PODXL TAB2 ZEB2 TSC22D1 KANSL1 ARID2 DMD HECTD1	3.37e-04	807	120	12	M16651
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L21 UBAP2 USP17L20 USP17L11 USP17L5 PEX14 USP17L10 WTAP NEDD4 USP17L18 BMPR2 USP17L17 TMEM123 USP17L15 USP17L13	3.83e-04	1198	120	15	MM1062
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	ZC3H13 AFF3 MDFI NEDD4 KANSL1 NUFIP2 MLLT3 HSPA8 RBFOX2	3.97e-04	484	120	9	MM999
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	HIVEP2 CDKN2AIP SEC24A FNBP4 ZEB2 TSC22D1 DST MEGF9 MTUS1 CBFA2T2 GOLGA5 LRIF1	3.98e-04	822	120	12	M6782
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	SLAIN2 SP3 ING3 EPB41L4B CDKN2AIP SEC24A ROR2 SIX4 ZEB2 ZBTB44 MEGF9 MLLT3 ZFR	1.80e-06	492	111	13	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000	DPP4 SP3 PODXL ROR1 AFF3 MUC16 LRRC4C TEX15 ZEB2 ADAMTS12 TSC22D1 GLI2 CD34 HSPA8 WNK3	2.80e-05	831	111	15	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000	SLAIN2 SP3 ING3 EPB41L4B CDKN2AIP SEC24A ROR2 SIX4 NEB ZEB2 ZBTB44 DST MEGF9 MLLT3 ZFR	3.00e-05	836	111	15	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	DPP4 SP1 SP3 ZC3H13 AFF3 FNBP4 ZEB2 ZBTB44 KANSL1 ADGRG2	5.41e-05	406	111	10	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	DPP4 SP1 SP3 ZC3H13 FNBP4 ZEB2 ZBTB44 KANSL1 ADGRG2 RBFOX2	6.24e-05	413	111	10	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_top-relative-expression-ranked_100	DPP4 PODXL RASSF10 C2CD3 KANSL1	7.92e-05	84	111	5	gudmap_developingKidney_e15.5_stage III -IV renal corpusc_100
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	DPP4 PODXL ROR1 AFF3 MUC16 LRRC4C TEX15 PHF8 ZEB2 ADAMTS12 GLI2 CD34 HSPA8 WNK3	1.05e-04	827	111	14	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	RANBP2 LRRC4C NEB DST MEGF9 MTUS1 BAZ1A SERPING1 MLLT3 ZC3H12C DMD TMEM123	1.61e-04	654	111	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000	SP3 BMP2K PODXL AFF3 MUC16 LRRC4C TEX15 PHF8 ZEB2 ADAMTS12 SERPING1 HSPA8 WNK3	2.27e-04	783	111	13	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4	SP4 LRRC4C NEB C2CD3 DST MEGF9 MTUS1 BAZ1A MLLT3 ZC3H12C DMD TMEM123	2.40e-04	683	111	12	Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	DPP4 SP1 SP3 ZC3H13 AFF3 FNBP4 ZEB2 ZBTB44 KANSL1 MEGF9 ADGRG2 ZFR RBFOX2	2.48e-04	790	111	13	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	SLAIN2 SP3 PODXL ARHGAP26 ROR2 TAB2 USP17L10 SIX4 EMSY PHC1 BAZ1A GLI2 IPCEF1 ETAA1 MLLT3 LRIF1 WNK3	2.66e-04	1252	111	17	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000	DPP4 SP1 SP3 SP4 ZC3H13 AFF3 FNBP4 ZEB2 ZBTB44 KANSL1 ADGRG2 CD34 SERPING1	2.69e-04	797	111	13	gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500	DPP4 SP1 SP3 ZC3H13 AFF3 FNBP4 ZEB2 ZBTB44 ADGRG2	2.73e-04	404	111	9	gudmap_developingGonad_e18.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	DPP4 SP1 SP3 SP4 ZC3H13 AFF3 FNBP4 ZEB2 HIVEP3 ZBTB44 KANSL1 ADGRG2 RBFOX2	2.83e-04	801	111	13	gudmap_developingGonad_e14.5_ epididymis_1000
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ROR1 ROR2 AFF3 MDFI ZEB2 ADAMTS12 DST GLI2	4.12e-08	194	115	8	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ROR1 ROR2 AFF3 MDFI ZEB2 ADAMTS12 DST GLI2	4.29e-08	195	115	8	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	ZC3H13 ZEB2 BPTF TSC22D1 BMPR2 KMT2A MLLT3 RBFOX2	4.83e-08	198	115	8	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	ROR1 TAB2 RYK BPTF ZBTB44 KANSL1 KMT2A DMD	5.02e-08	199	115	8	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	SLAIN2 ZC3H13 BPTF MTUS1 ANKRD17 ZFR MUC4	7.28e-08	138	115	7	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP3 BMP2K ZEB2 WTAP DST IPCEF1 NUFIP2	3.40e-07	173	115	7	869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP3 BMP2K ZEB2 WTAP DST IPCEF1 NUFIP2	3.40e-07	173	115	7	0672bd8a4a9d18af343d01f09253fb3388896c10
ToppCell	facs-Brain_Myeloid-Cerebellum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SP3 BMP2K ZEB2 WTAP DST IPCEF1 NUFIP2	3.40e-07	173	115	7	870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RANBP2 ZEB2 NEDD4 BMPR2 NUFIP2 ZFR DMD	3.82e-07	176	115	7	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 AFF3 MDFI ZEB2 ADAMTS12 GLI2 DMD	4.12e-07	178	115	7	78a0c6340001a77f5b2d890b6263f574af2e72da
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 ROR2 ADAMTS12 MTUS1 GLI2 HFM1 DMD	5.34e-07	185	115	7	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RANBP2 ARHGAP26 ZEB2 KANSL1 ARID2 NUFIP2 KMT2A	5.95e-07	188	115	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 ROR1 ROR2 KANSL1 MTUS1 ARID2 KMT2A	5.95e-07	188	115	7	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 ROR1 ROR2 KANSL1 MTUS1 ARID2 KMT2A	5.95e-07	188	115	7	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 ROR1 ROR2 KANSL1 MTUS1 ARID2 KMT2A	5.95e-07	188	115	7	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR1 ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	6.39e-07	190	115	7	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR1 ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	6.62e-07	191	115	7	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR1 ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	6.62e-07	191	115	7	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PODXL AFF3 NEDD4 BMPR2 DST CD34 ZC3H12C	7.35e-07	194	115	7	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PODXL AFF3 NEDD4 BMPR2 DST CD34 ZC3H12C	7.35e-07	194	115	7	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	DPP4 HIVEP2 TAB2 DST KMT2A TMEM123 HSPA8	7.61e-07	195	115	7	22191d361af136942508f1553ff41a626ed982ad
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	ROR1 AFF3 HIVEP3 KANSL1 MLLT3 DMD RBFOX2	7.88e-07	196	115	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	PCW_05-06-Mesenchymal\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ROR1 ROR2 AFF3 MDFI ZEB2 ADAMTS12 GLI2	7.88e-07	196	115	7	dca52c57ba35d9395cdbca8b881f12ece721b10f
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	DPP4 HIVEP2 OBSCN FNBP4 IPCEF1 KMT2A MLLT3	8.15e-07	197	115	7	836dd8110d5689f944ad1d301def38c32278b5b5
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	HIVEP2 AFF3 ZEB2 HIVEP3 TSC22D1 MLLT3 RBFOX2	9.02e-07	200	115	7	84e4565d28a02700bf7f6730d1b3a58744ca0aea
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Mild / Disease, condition lineage and cell class	DPP4 HIVEP2 OBSCN DST IPCEF1 TMEM123 HSPA8	9.02e-07	200	115	7	d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 DPP4 TIGD1 USF3 DPEP2 MPHOSPH9	1.89e-06	142	115	6	d52da766e031f7409eb5a7a9fa88f48e14a79d8b
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Epi-like\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 DPP4 TIGD1 USF3 DPEP2 MPHOSPH9	1.89e-06	142	115	6	a05b320cf182b2aaf18df7c40045dc65b659bf20
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	GARIN5B EPB41L4B BEST3 LRRC4C ADGRG2 WNK3	2.49e-06	149	115	6	c5eedb54ef2e0f131aa6730612c921bc19479632
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	GARIN5B EPB41L4B BEST3 LRRC4C ADGRG2 WNK3	2.49e-06	149	115	6	a22417286de8606f0cc94f86b70bce17aeefb9c2
ToppCell	facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K OBSCN ZEB2 HIVEP3 TSC22D1 ZC3H12C	7.40e-06	180	115	6	bf8d13d4db1af55b8c9fe16aaccf8743e000e005
ToppCell	facs-Marrow-B-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K OBSCN ZEB2 HIVEP3 TSC22D1 ZC3H12C	7.40e-06	180	115	6	839defb40f7cfb2711e9025194de636533f51bcd
ToppCell	390C-Fibroblasts-Fibroblast-G\|390C / Donor, Lineage, Cell class and subclass (all cells)	MDFI ADAMTS12 DST ADGRG2 GLI2 SERPING1	7.40e-06	180	115	6	137fc14859c89e1ecd98bee388bb58c04b835847
ToppCell	facs-Marrow-B-cells-3m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K OBSCN ZEB2 HIVEP3 TSC22D1 ZC3H12C	7.40e-06	180	115	6	82965ed1b72a1873c24dd4553d39681596057316
ToppCell	390C-Fibroblasts-Fibroblast-G-\|390C / Donor, Lineage, Cell class and subclass (all cells)	MDFI ADAMTS12 DST ADGRG2 GLI2 SERPING1	7.40e-06	180	115	6	cd6790de050151fedfa2c5ea6ad58b72665414b2
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AFF3 ZEB2 ADAMTS12 GLI2 DMD ANKFN1	7.88e-06	182	115	6	44764676ed3f51ba171ce63f669390392fa50a43
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AFF3 ZEB2 ADAMTS12 GLI2 DMD ANKFN1	7.88e-06	182	115	6	d82f59a3f930a840dde27dc6ab024f227a26d446
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 ROR1 ROR2 MDFI GLI2 DMD	8.13e-06	183	115	6	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	Control-Epithelial_cells-Airway_mucous\|Control / group, cell type (main and fine annotations)	ARHGAP26 MUC16 MUC17 MUC4 MUC5AC MGAM2	8.13e-06	183	115	6	15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	8.38e-06	184	115	6	c5436a8e45f471b8d1301abbe9c7879204537f52
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ROR1 AFF3 OBSCN NEB TSC22D1 DMD	9.48e-06	188	115	6	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	9.77e-06	189	115	6	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	9.77e-06	189	115	6	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	COVID-19-Heart-EC_(POSTN)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PODXL ARHGAP26 F5 F8 MTUS1 CD34	9.77e-06	189	115	6	7346c1112e2e155dbd71b6dbc80e680fd262a691
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 ROR1 ROR2 MTUS1 GLI2 DMD	9.77e-06	189	115	6	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PODXL AFF3 NEDD4 BMPR2 CD34 ZC3H12C	1.01e-05	190	115	6	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	COVID-19-Endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	PODXL AFF3 MCAM F8 BMPR2 CD34	1.01e-05	190	115	6	9fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AFF3 ZEB2 ADAMTS12 GLI2 DMD ANKFN1	1.04e-05	191	115	6	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PODXL AFF3 NEDD4 BMPR2 CD34 ZC3H12C	1.04e-05	191	115	6	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	1.04e-05	191	115	6	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	1.04e-05	191	115	6	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK3 ROR1 ROR2 MTUS1 GLI2 DMD	1.04e-05	191	115	6	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AFF3 ZEB2 ADAMTS12 GLI2 DMD ANKFN1	1.04e-05	191	115	6	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_A_+_HSC\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MDFI NEDD4 TSC22D1 DST CD34 MLLT3	1.07e-05	192	115	6	959c28d28397bc0b9d3970d1fe3293d2750e63d4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	1.07e-05	192	115	6	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	1.07e-05	192	115	6	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DPP4 HIVEP2 TAB2 CRYBG1 MLLT3 TMEM123	1.10e-05	193	115	6	194b49c152e3e3f599068ec88a7f0af6427b743a
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PODXL AFF3 NEDD4 BMPR2 CD34 ZC3H12C	1.10e-05	193	115	6	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	1.13e-05	194	115	6	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ROR1 NACA AFF3 MDFI ZEB2 ADAMTS12	1.13e-05	194	115	6	28c5482da199bcee9e85258a88af453d9fdbd56a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	1.13e-05	194	115	6	cf0244a29934e515446ac917d3c30672b460fb04
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	1.13e-05	194	115	6	ba7f971fb9a19423602da60770f23d9fead4a451
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	1.13e-05	194	115	6	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DPP4 HIVEP2 IPCEF1 CRYBG1 MLLT3 HSPA8	1.13e-05	194	115	6	a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NACA IPCEF1 CRYBG1 MLLT3 TMEM123 HSPA8	1.17e-05	195	115	6	e4caa01d2040a6f4dd90e68c2e1e99c5405e2eba
ToppCell	Mild/Remission-B_naive-8\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	AFF3 ZEB2 PHC1 HIVEP3 BPTF TMEM123	1.17e-05	195	115	6	0a3221e4d1fa31a35868bdda0f0cc873c233b407
ToppCell	facs-Skin-Telogen-3m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEDD4 DST MTUS1 CD34 DMD HSPA8	1.20e-05	196	115	6	90edf61116ffcb4f8b6be3d0a05732d59b0a87d5
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	DPP4 PODXL AFF3 F5 ADAMTS12 HEY2	1.20e-05	196	115	6	24d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCell	PCW_07-8.5-Mesenchymal\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ROR1 ROR2 MDFI ZEB2 ADAMTS12 GLI2	1.20e-05	196	115	6	8e10802f52e5e1853ea4ad34bf9a32a34e6112b5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	1.20e-05	196	115	6	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ROR2 AFF3 ZEB2 ADAMTS12 GLI2 DMD	1.20e-05	196	115	6	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	DPP4 HIVEP2 BAZ1A IPCEF1 CRYBG1 TMEM123	1.24e-05	197	115	6	479841809554a9d0b1e4f23da6e657392b0f4971
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	PODXL AFF3 F8 NEDD4 BMPR2 CD34	1.24e-05	197	115	6	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ROR1 ROR2 ZEB2 ADAMTS12 DST GLI2	1.24e-05	197	115	6	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	healthy_donor-Lymphocytic-T_cell-CD4+_Naive_T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	DPP4 HIVEP2 OBSCN IPCEF1 MLLT3 TMEM123	1.24e-05	197	115	6	cf72160f03105876641fa6fdc7405e339eb084c7
ToppCell	healthy_donor-Lymphocytic-T_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	DPP4 HIVEP2 OBSCN IPCEF1 KMT2A TMEM123	1.24e-05	197	115	6	63d0f06e150e7eb800ecb70e97b9d12a01c84e37
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	ROR1 ROR2 LRRC4C MDFI ADAMTS12 HIVEP3	1.24e-05	197	115	6	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PODXL TSC22D1 BMPR2 MTUS1 CD34 HEY2	1.27e-05	198	115	6	8a55589b9244283e4b0b423a4a6d6202e8e0fec9
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PODXL AFF3 F8 BMPR2 CD34 TMEM123	1.27e-05	198	115	6	d5990cab01de6e6f3757f5a50ef70ced711bb1fa
ToppCell	COVID_vent-Lymphocytic-T_cell-CD4+_Memory_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	DPP4 HIVEP2 TAB2 KMT2A TMEM123 HSPA8	1.27e-05	198	115	6	58f208b76cb0adcecdf632d92f92833a06f9bf71
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	PODXL AFF3 MCAM F8 BMPR2 CD34	1.31e-05	199	115	6	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	SLAIN2 ZC3H13 BPTF MTUS1 BAZ1A ZFR	1.31e-05	199	115	6	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	PCW_10-12-Mesenchymal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ROR1 ROR2 ZEB2 ADAMTS12 DST GLI2	1.31e-05	199	115	6	a09292de4c4447b8eee55d401808e43b817321cc
ToppCell	COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	DPP4 HIVEP2 OBSCN TAB2 MLLT3 TMEM123	1.31e-05	199	115	6	885bc902b6e2af0b61e452c4154160cd3f1cf98e
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP26 AFF3 KANSL1 MLLT3 DMD RBFOX2	1.31e-05	199	115	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_\|World / Primary Cells by Cluster	HIVEP2 AFF3 ZEB2 TSC22D1 MLLT3 RBFOX2	1.31e-05	199	115	6	058373b4ac3cec2108cb24265628ff0a50646e33
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	ROR2 ZEB2 ADAMTS12 DST GLI2 DMD	1.31e-05	199	115	6	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	AFF3 ZEB2 HIVEP3 TSC22D1 MLLT3 RBFOX2	1.35e-05	200	115	6	1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related-Oligodendrocyte/OPC\|3m / Sample Type, Dataset, Time_group, and Cell type.	NACA MDFI BAZ1A CBFA2T2 ZC3H12C TMEM123	1.35e-05	200	115	6	7557ea33c3d080d0fa4ca0c2703279932d01e6d0
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	HIVEP2 NEDD4 BMPR2 CD34 SERPING1 KMT2A	1.35e-05	200	115	6	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-OPC_related\|3m / Sample Type, Dataset, Time_group, and Cell type.	NACA MDFI BAZ1A CBFA2T2 ZC3H12C TMEM123	1.35e-05	200	115	6	3dcaeb9f1e387784c299bfe0da1516598f82edf5
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZEB2 BPTF KANSL1 NUFIP2 SERPING1 KMT2A	1.35e-05	200	115	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK3 PODXL DMD TMEM123 MUC7 MGAM2	1.35e-05	200	115	6	7c2d499af60654b7b28f172ac2c914ad49fb74b4
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	OBSCN RASSF10 MDFI TSC22D1 DST MUC4	1.35e-05	200	115	6	9da214f756a03516eaafde00289b90f69623b9f3
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MUC16 TSC22D1 DST MTUS1 HECTD1 MUC4	1.35e-05	200	115	6	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-7\|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9	TAB2 NEDD4 CD34 KMT2A MLLT3	3.74e-05	145	115	5	88090a226ddfa6df59976f025bf0fd84ca0f72ef
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLAIN2 DPP4 TIGD1 PHC1 MUC17	4.54e-05	151	115	5	29d91a7d1470121af45fb8bb35175f2acced4551
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLAIN2 DPP4 TIGD1 PHC1 MUC17	4.54e-05	151	115	5	9ebfbdccc9656fce8990d06622f225009633f07c
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	ZC3H13 TSC22D1 MLLT3 HSPA8 RBFOX2	5.15e-05	155	115	5	9d53caee196b5c2bbc90c4f54f693b64d4086065
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ARHGAP26 ROR1 MUC16 ZEB2 MUC6	5.47e-05	157	115	5	f2bc60ec0305b056d79f1b7fd6b5e3730d606916
Drug	Gramine [87-52-5]; Up 200; 23uM; HL60; HT_HG-U133A	SP1 SEC24A ZC3H13 AFF3 MCAM MTUS1 CD34 KMT2A MLLT3	4.26e-07	190	112	9	2143_UP
Drug	Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; HL60; HT_HG-U133A	UBE4B PEX14 PHF8 ZBTB44 ETAA1 ZFR MPHOSPH9 RBFOX2	6.23e-06	198	112	8	2369_DN
Drug	SP 0	SP1 SP3 SP4	1.36e-05	10	112	3	CID002742752
Drug	Chloroprene	SP1 ZC3H13 AFF3 SIX4 F5 ZEB2 EMSY NEDD4 HIVEP3 BPTF BMPR2 TREML4 MTUS1 IPCEF1 ARID2 MLLT3 ZC3H12C HECTD1 HSPA8	3.01e-05	1348	112	19	ctd:D002737
Drug	J NH	DPP4 SP4 MUC7	3.20e-05	13	112	3	CID005459374
Drug	cellobiitol	MUC3B MUC4 MUC5AC MUC7	3.23e-05	37	112	4	CID000003871
Drug	AC1L1B35	DOCK3 SP1 SP3 SP4 CD34	3.24e-05	74	112	5	CID000001263
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	BMP2K UBE4B SEC24A NEDD4 BPTF BAZ1A RBFOX2	3.95e-05	187	112	7	4989_DN
Drug	Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A	SP1 HIVEP2 BMP2K EMSY BPTF CBFA2T2 ETAA1	4.98e-05	194	112	7	4391_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A	ZNF280A DPP4 ADAMTS12 HIVEP3 CBFA2T2 KMT2A MUC6	5.15e-05	195	112	7	5582_UP
Drug	Mefenamic acid [61-68-7]; Up 200; 16.6uM; PC3; HT_HG-U133A	ARHGAP26 PEX14 MTUS1 ADGRG2 CBFA2T2 TUBGCP3 ZFR	5.32e-05	196	112	7	1821_UP
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A	DPP4 ARHGAP26 ADGRG2 CBFA2T2 MUC4 MUC5AC MUC6	5.32e-05	196	112	7	3571_UP
Drug	Colistin sulfate [1264-72-8]; Up 200; 3uM; HL60; HT_HG-U133A	SP4 ZC3H13 ROR2 MCAM MTUS1 CBFA2T2 RBFOX2	5.32e-05	196	112	7	2491_UP
Drug	ICI 182,780; Up 200; 0.01uM; HL60; HT_HG-U133A	DPP4 MDFI EMSY OPRPN MTUS1 CD34 KMT2A	5.67e-05	198	112	7	6197_UP
Drug	S(-)-terguride hydrogen maleate [37686-85-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A	MCAM TEX15 ADAMTS12 HIVEP3 IPCEF1 CBFA2T2 TAB1	5.67e-05	198	112	7	5694_UP
Drug	Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; HL60; HG-U133A	ZNF280A BMP2K SEC24A ZEB2 HIVEP3 ZFR MPHOSPH9	5.67e-05	198	112	7	1976_UP
Drug	Cefotiam hydrochloride; Up 200; 7.2uM; PC3; HT_HG-U133A	BMP2K AFF3 NEB EMSY OPRPN MUC5AC MUC7	5.67e-05	198	112	7	6762_UP
Drug	Quinidine hydrochloride monohydrate [6151-40-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A	SP1 BMP2K PODXL NEB F5 ADGRG2 CBFA2T2	5.67e-05	198	112	7	6267_UP
Drug	Flutamide [13311-84-7]; Up 200; 14.4uM; PC3; HT_HG-U133A	BMP2K ADAMTS12 MTUS1 IPCEF1 CD34 MUC4 MUC5AC	5.85e-05	199	112	7	4539_UP
Drug	homocysteic acid	SP1 SP3	7.17e-05	3	112	2	ctd:C007956
Drug	Boc-leu-ser-thr-arg-mca	F5 F8	7.17e-05	3	112	2	CID000189792
Drug	DTPA-BMA	NACA CD34	7.17e-05	3	112	2	CID000060755
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 USP17L15 USP17L13	3.31e-15	46	121	10	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L21 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L18 USP17L17 KMT2A USP17L15 USP17L13	5.17e-15	69	121	11	DOID:1682 (implicated_via_orthology)
Disease	mucinous adenocarcinoma (is_marker_for)	MUC4 MUC5AC MUC6	6.69e-07	5	121	3	DOID:3030 (is_marker_for)
Disease	intellectual disability (implicated_via_orthology)	ZNF280A HIVEP2 RYK KANSL1 RBFOX2	1.46e-05	75	121	5	DOID:1059 (implicated_via_orthology)
Disease	keratoconjunctivitis (is_marker_for)	MUC16 MUC5AC	4.99e-05	3	121	2	DOID:9368 (is_marker_for)
Disease	red blood cell density measurement	SP1 SP3 SP4 BMP2K PODXL AFF3 ZEB2 DST KANSL1 BAZ1A DPEP2 ARID2 MUC4	6.83e-05	880	121	13	EFO_0007978
Disease	JT interval	SP3 CACUL1 NACA OBSCN STAU1 ARID2 HEY2	7.62e-05	248	121	7	EFO_0007885
Disease	congenital heart disease (is_implicated_in)	SP4 TAB2 RBFOX2	1.28e-04	24	121	3	DOID:1682 (is_implicated_in)
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC4 MUC5AC MUC6	1.41e-04	64	121	4	DOID:4947 (is_marker_for)
Disease	biliary tract benign neoplasm (is_marker_for)	MUC4 MUC5AC	3.46e-04	7	121	2	DOID:0050625 (is_marker_for)
Disease	legumain measurement	PHC1 GOLGA5	3.46e-04	7	121	2	EFO_0020530
Disease	reaction time measurement	DPP4 PODXL TOPAZ1 RASSF10 LRRC4C STAU1 KANSL1 DPEP2 NUFIP2 MLLT3	3.91e-04	658	121	10	EFO_0008393
Disease	obsolete_red blood cell distribution width	SP1 SP3 BMP2K F8 BMPR2 KANSL1 MUC17 CBFA2T2 NUFIP2 CRYBG1 HFM1 MUC4 HSPA8 WNK3 RBFOX2	4.16e-04	1347	121	15	EFO_0005192
Disease	neuroimaging measurement	SP1 UBAP2 PODXL ROR1 ROR2 AFF3 KANSL1 BAZ1A CBFA2T2 HEY2 TMEM123 ANKFN1 UBE2Z	4.55e-04	1069	121	13	EFO_0004346
Disease	common bile duct neoplasm (is_marker_for)	MUC4 MUC5AC	4.59e-04	8	121	2	DOID:4608 (is_marker_for)
Disease	Lymphoid leukemia	IPCEF1 KMT2A	4.59e-04	8	121	2	C0023448
Disease	3-hydroxypropylmercapturic acid measurement	UBAP2 TOPAZ1 LINGO2 EMSY ADGRG2 KMT2A MUC4	6.40e-04	352	121	7	EFO_0007014
Disease	dry eye syndrome (is_marker_for)	MUC16 MUC5AC	7.35e-04	10	121	2	DOID:10140 (is_marker_for)
Disease	pancreatic carcinoma	ROR1 NACA RASSF10 DST ETAA1	7.71e-04	174	121	5	EFO_0002618
Disease	pancreatic cancer (is_marker_for)	MUC16 MUC4 MUC5AC MUC6	8.08e-04	101	121	4	DOID:1793 (is_marker_for)
Disease	atrial fibrillation	UBE4B ARHGAP26 NACA BEST3 TAB2 RXRG MLLT3	8.70e-04	371	121	7	EFO_0000275
Disease	Gastrointestinal Stromal Sarcoma	C2CD3 GLI2 DMD	9.56e-04	47	121	3	C3179349
Disease	sialate O-acetylesterase measurement	LINGO2 GOLGA5	1.07e-03	12	121	2	EFO_0803073
Disease	asthma	DOCK3 DPP4 HIVEP2 AFF3 MUC16 PEX14 EMSY IPCEF1 MLLT3 MUC5AC	1.08e-03	751	121	10	MONDO_0004979
Disease	Hypermetropia, Myopia	LRRC4C RYK HIVEP3 BPTF MLLT3	1.12e-03	189	121	5	HP_0000540, HP_0000545
Disease	prostate carcinoma	SP3 UBAP2 PEX14 SIX4 EMSY WTAP NEDD4 DPEP2 TUBGCP3 LRIF1 WNK3	1.12e-03	891	121	11	EFO_0001663
Disease	Gastrointestinal Stromal Tumors	C2CD3 GLI2 DMD	1.15e-03	50	121	3	C0238198
Disease	refractive error, age at onset, Myopia	LRRC4C ZEB2 HIVEP3 ARID2 CD34	1.22e-03	193	121	5	EFO_0004847, HP_0000545, MONDO_0004892
Disease	juvenile polyposis syndrome (implicated_via_orthology)	HIVEP2 HIVEP3	1.26e-03	13	121	2	DOID:0050787 (implicated_via_orthology)
Disease	trait in response to apixaban	UBE4B LINGO2 ADAMTS12 DMD	1.31e-03	115	121	4	OBA_2050328
Disease	serum IgG glycosylation measurement	HIVEP2 TOPAZ1 LINGO2 LRRC4C USF3 TAB1 GOLGA5 ANKFN1	1.45e-03	523	121	8	EFO_0005193
Disease	gastric ulcer (implicated_via_orthology)	MUC5AC MUC6	1.47e-03	14	121	2	DOID:10808 (implicated_via_orthology)
Disease	tetralogy of Fallot (implicated_via_orthology)	PHC1 HEY2	1.47e-03	14	121	2	DOID:6419 (implicated_via_orthology)
Disease	alcohol dependence measurement	PODXL LINGO2 BPTF	1.51e-03	55	121	3	EFO_0007835
Disease	diffuse idiopathic skeletal hyperostosis	ROR2 ANKFN1	1.69e-03	15	121	2	EFO_0007236
Disease	waist circumference	ARHGAP26 LINGO2 TEX15 BPTF MLLT3 TAB1 DMD	2.00e-03	429	121	7	EFO_0004342
Disease	otitis media (biomarker_via_orthology)	MUC4 MUC5AC	2.18e-03	17	121	2	DOID:10754 (biomarker_via_orthology)
Disease	wellbeing measurement	SLAIN2 HIVEP2 FNBP4 RASSF10 LINGO2 TEX15 STAU1 BPTF KMT2A	2.24e-03	692	121	9	EFO_0007869
Disease	Neoplastic Cell Transformation	SP1 ZEB2 TSC22D1 CD34	2.62e-03	139	121	4	C0007621
Disease	eosinophil percentage of granulocytes	DOCK3 EMSY HIVEP3 BPTF KANSL1	2.83e-03	234	121	5	EFO_0007996
Disease	basophil count, eosinophil count	DOCK3 EMSY HIVEP3 BPTF KANSL1	3.22e-03	241	121	5	EFO_0004842, EFO_0005090
Disease	Deep Vein Thrombosis	F5 F8	3.33e-03	21	121	2	C0149871
Disease	Venous Thrombosis	F5 F8	3.33e-03	21	121	2	C0042487
Disease	osteoporosis	SP1 UBAP2 LRRC4C	3.39e-03	73	121	3	EFO_0003882
Disease	Alzheimer disease, educational attainment	DOCK3 DPP4 AFF3 STAU1 KANSL1	3.57e-03	247	121	5	EFO_0011015, MONDO_0004975
Disease	Primary microcephaly	PHC1 TUBGCP3	3.65e-03	22	121	2	C0431350
Disease	eosinophil percentage of leukocytes	DOCK3 HIVEP2 ARHGAP26 EMSY PHC1 HIVEP3 BPTF KANSL1 MUC5AC	3.68e-03	746	121	9	EFO_0007991
Disease	visceral adipose tissue measurement	HIVEP2 ROR2 RASSF10 LINGO2 HIVEP3 BPTF CRYBG1	3.76e-03	481	121	7	EFO_0004765
Disease	urate measurement, bone density	UBE4B PODXL PEX14 GRIN2C LRRC4C FSIP2 GLI2 CD34	4.06e-03	619	121	8	EFO_0003923, EFO_0004531
Disease	reticulocyte measurement	SP1 UBAP2 BMP2K AFF3 ZEB2 STAU1 BMPR2 KANSL1 MEGF9 BAZ1A UBE2Z	4.08e-03	1053	121	11	EFO_0010700

Protein segments in the cluster

Peptide	Gene	Start	Entry
SSTISTNTPSQGICN	ZNF280A	201	P59817
SQTSTLQSLTPQSSV	BEST3	476	Q8N1M1
SRAQNQPSSICSTTT	AFF3	116	P51826
SSSSSSFTPSQTRQQ	MLLT3	386	P42568
LQSSSNSTNSTTLLV	ADGRG2	931	Q8IZP9
CTSTVSQGQQLITTS	ARID2	811	Q68CP9
STAQISQAVTTTQPS	DMD	661	P11532
SQAVTTTQPSLTQTT	DMD	666	P11532
TTVTTTASNNNTAPT	ANKRD17	2011	O75179
SSVQLPSTLSTQSAC	ANKRD17	2216	O75179
ANSATTATPSVLTIQ	BMP2K	376	Q9NSY1
TSATTTSIQPNLENS	BPTF	696	Q12830
PQVQSSTQTLSSGQT	BPTF	2521	Q12830
STQTLSSGQTLNQVT	BPTF	2526	Q12830
SSGQTLNQVTVSSPS	BPTF	2531	Q12830
STSQPILTSQSLSIQ	ADAMTS12	1086	P58397
STVSTNASTPQSVSS	BAZ1A	1061	Q9NRL2
SQTLSPVTSSSVASQ	CCDC27	206	Q2M243
APTASSTININTSTS	CACUL1	106	Q86Y37
RQQQTPSSCSSTSSS	RASSF10	191	A6NK89
SKQNQTTAISTPASS	RANBP2	1751	P49792
QSSNSPSTQNGSLTT	RBFOX2	81	O43251
TSSVIRLNSPTTTSQ	HEY2	31	Q9UBP5
DTSVSTSTPNISQTN	MUC16	5461	Q8WXI7
SQINTLNTLTPVTTS	MUC4	336	Q99102
STNQELPGTTATQTT	MUC6	1346	Q6W4X9
SATTPVSTTNQLSSS	MUC6	2116	Q6W4X9
TSTATAKPNTTSSQN	PODXL	136	O00592
QTQISSSSTSASVQL	LRIF1	81	Q5T3J3
TSQLTSSQSSAGPQS	NEDD4	806	P46934
TSTTNASTNATVPIT	MGAM2	1886	Q2M2H8
TNTTTASTNATIPIT	MGAM2	1966	Q2M2H8
TTINNISTPVQTNTT	MGAM2	2136	Q2M2H8
ISTPVQTNTTNASTS	MGAM2	2141	Q2M2H8
QATCNQSLLTSISTS	ERVS71-1	361	P61550
QTSASSPSSVNSRQQ	MTUS1	536	Q9ULD2
RSESNSSITTTQPTI	DST	7361	Q03001
KTPVFQSSQTSSVSS	GOLGA5	146	Q8TBA6
QSSQTSSVSSVNPSV	GOLGA5	151	Q8TBA6
TSVSNLLTPSVKTSQ	KIAA2026	1191	Q5HYC2
LASKSSSQTSTSQLP	CDKN2AIP	396	Q9NXV6
LTSQISPLNTSAEQS	FSIP2	4801	Q5CZC0
SSSSTVVQEISQQTT	ING3	326	Q9NXR8
SSTSSALTNQQLPAT	CBFA2T2	96	O43439
QLLLTSTDQQTVSSS	FAM205A	616	Q6ZU69
QLLLTSTDQQTVSSS	FAM205BP	346	Q63HN1
SLSSTDVSPNQSNTS	MPHOSPH9	236	Q99550
ASSSSQVTASTSQQP	KANSL1	836	Q7Z3B3
NSTFTPTTLQTIFSV	MEGF9	481	Q9H1U4
PTTLQTIFSVSTSEN	MEGF9	486	Q9H1U4
LTSLSVTNTNLSTVP	LINGO2	251	Q7L985
LSSVTNATSIQITAP	DPP4	276	P27487
LTSINATPTQLSSSS	GLI2	331	P10070
TLTANQPSSQATTSK	TUBGCP3	206	Q96CW5
KVSSTSNNLISTIPS	F8	896	P00451
TTNVTTSLTPQSTRS	LRRC4C	486	Q9HCJ2
AQTTPSTTSKTTETQ	MUC5AC	1861	P98088
NPGSISVQTSLTNSS	ETAA1	696	Q9NY74
QSVSQTLKNTSTAIP	HFM1	436	A2PYH4
QTTSATLTVTALPAQ	OBSCN	3261	Q5VST9
PKTTSVSQNTSQIST	TMEM123	116	Q8N131
SVTTQTTTTKQPTSA	MUC7	336	Q8TAX7
TVLSVGQSLSNTLTT	HECTD1	1626	Q9ULT8
QSLTAQQASSSSPSL	IPCEF1	176	Q8WWN9
LTTSPLSSQTSILTS	C2CD3	1871	Q4AC94
SVTNVSVLSSSQASP	DOCK3	1726	Q8IZD9
TSLSTNTTTTNTTGL	BMPR2	606	Q13873
PTTNSTTNSATKITA	SERPING1	66	P05155
SSSKSTTSQIPLQAQ	MDFI	146	Q99750
STTLSSPSTQGLQEQ	DPEP2	61	Q9H4A9
LSTLQSAPQQQTSSS	KMT2A	546	Q03164
ITFTKPSTQTTNTTT	EMSY	261	Q7Z589
PSTQTTNTTTQKVII	EMSY	266	Q7Z589
QNGSLSQSSVSQPTT	CRYBG1	866	Q9Y4K1
QQQSQASAPSTSRTT	WTAP	241	Q15007
ASSSSQGLSQPSTQT	RYK	266	P34925
TTTNTTTAATQVSVP	EPB41L4B	701	Q9H329
TNSSVQSQTSVISTV	CD34	106	P28906
RNTTIPTKQTQTFTT	HSPA8	416	P11142
SSQASSSPATLQVTT	MUC17	3551	Q685J3
LVNLTTLTPDSNTTT	MCAM	516	P43121
ARTSQTSVATTQTPT	MUC3B	831	Q9H195
TLQQSQPISAGATTT	RNF186	6	Q9NXI6
SAPSTQQVLSLSTSA	TAF6	546	P49848
NGNQLVSTPTNTTTS	SP4	296	Q02446
PGSQEITQLTQTTSS	SLAIN2	486	Q9P270
NQSPTLTLQSTNTHT	TAB1	436	Q15750
PRTSSTSSSVNSQTL	TAB2	346	Q9NYJ8
SQVTLSPELSQTNLS	F5	1191	P12259
LKPSAQTTVVTSQSS	FNBP4	761	Q8N3X1
SSQPTVSGNTSLTTN	SEC24A	156	O95486
SVSSNPNSILNSSSS	ARHGAP26	626	Q9UNA1
PVASKSTVTSVSNTN	SIX4	646	Q9UIU6
VQVTTSNQTILSSPA	OPRPN	221	Q99935
NTTQTSSLSTSPVSN	ROR2	766	Q01974
VTPAQISASISSNNS	TSC22D1	116	Q15714
SLGQTSSSNTTLTPI	SP1	491	P08047
SGSVAQTVTQLQTTL	PEX14	156	O75381
QSIPISSSSSTVLQT	ANKFN1	496	Q8N957
QTQSLTAQQASSSSP	CNK3/IPCEF1	636	G9CGD6
ATTQTTSLSASPVSN	ROR1	766	Q01973
GQFTTTPSTQQNSTS	UBAP2	386	Q5T6F2
QQTSPSRCTLLVTSS	TREML4	56	Q6UXN2
QQSSSLSLAVSSSPT	TEP1	1666	Q99973
LNKTIQNSSVSPTSS	NUFIP2	366	Q7Z417
IQNSALPSASITSTS	STAU1	51	O95793
SAATTLTSQQPSTSR	TIGD1	561	Q96MW7
TGILQQNTNSLTTSS	SP3	346	Q02447
SSSPSNSLETQSQSL	UBE4B	86	O95155
EQQSSLLNLSSTTPT	USP17L18	481	D6R9N7
PVSASQSSLSDQQTV	ZBTB44	306	Q8NCP5
TTLSQILVTQSQGSS	HIVEP3	1336	Q5T1R4
EQQSSLLNLSSSTPT	USP17L5	481	A8MUK1
TTTTNSTQRPSQQLV	UNC93A	186	Q86WB7
EQQSSLLNLSSSTPT	USP17L21	481	D6R901
EQQSSLLNLSSSTPT	USP17L13	481	C9JLJ4
PSSQLNVVNSVSSSE	RXRG	96	P48443
SPNTSTTQQQTTTTQ	PHC1	86	P78364
TTQQQTTTTQASINL	PHC1	91	P78364
RSQSVSSPSATTLTQ	PHC1	116	P78364
QTTVPATVNLTVSSS	USF3	1266	Q68DE3
SPAQSISSVLISIQS	UBE2Z	201	Q9H832
ASSIQSPGTSTQILQ	TOPAZ1	1601	Q8N9V7
SLNSTSNTKVSAVPT	ZFR	476	Q96KR1
EQQSSLLNLSSSTPT	USP17L24	481	Q0WX57
NLQSSSSSPATSSLQ	PHF8	766	Q9UPP1
ATSTAKPQSTTSLSN	ZC3H12C	526	Q9C0D7
LPVSSTSQSTSQSVY	TEX15	1136	Q9BXT5
SVSSSPTNSAITQLR	ZEB2	356	O60315
IRSNSVPTSSATNLT	HIVEP2	541	P31629
EQQSSLLNLSSTTPT	USP17L15	481	C9J2P7
EQQSSLLNLSSSTPT	USP17L17	481	D6RBQ6
TISTSATPTNTTNNT	ZC3H13	1136	Q5T200
EQQSSLLNLSSTTPT	USP17L20	481	D6RJB6
EQQSSLLNLSSTTPT	USP17L10	481	C9JJH3
EQQSSLLNLSSTTPT	USP17L11	481	C9JVI0
NSTSTQTSNESAPQS	WNK3	851	Q9BYP7
FSIISSTANQTQSSP	GARIN5B	281	Q8N5Q1
LSLSTQSLPVVTSSQ	NACA	276	E9PAV3
SSSVATQQTTVSSIP	NEB	6591	P20929
TVGVNTTNPSSLLTQ	GRIN2C	66	Q14957